These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Untargeted-LCMS_DBS-ChemRxiv-2-2021-1.pdf (2.25 MB)

Nontargeted Mass Spectrometry of Dried Blood Spots for Interrogation of the Human Circulating Metabolome

submitted on 23.02.2021, 00:41 and posted on 23.02.2021, 11:24 by Casey Ward, Shriram Nallamshetty, Jeramie D. Wartrous, Eowyn Acres, Tao Long, Ian T Mathews, Sonia Sharma, Susan Cheng, Farhad Imam, Mohit Jain
Advances in high resolution, nontargeted mass spectrometry allow for the simultaneous measure of thousands of metabolites in a single biosample. Application of these analytical approaches to population-scale human studies has been limited by the need for resource-intensive blood sample collection, preparation, and storage. Dried blood spotting, a technique developed decades ago for newborn screening, may offer a simple approach to overcome barriers in human blood acquisition and storage. In this study, we find that over 4,000 spectral features across diverse chemical classes may be efficiently and reproducibly extracted and relatively quantified from human dried blood spots using nontargeted mass spectrometry-based metabolomics. Moreover, over 80% of metabolites were found to be chemically stable in dried blood spots stored at room temperature for up to a week. In direct relation to plasma samples, dried blood spots exhibited comparable representation of the human circulating metabolome, capturing both known and previously uncharacterized metabolites. Dried blood spot approaches provide an opportunity for rapid and facile human biosampling and storage, and will enable widespread metabolomics study of populations, particularly in resource-limited areas.





Email Address of Submitting Author


VAPAHCS, Stanford School of Medicine


United States of America

ORCID For Submitting Author


Declaration of Conflict of Interest

no conflict of interest

Version Notes

Version 1 with no revisions